Back to ABN AMRO Bank N.V. ABN AMRO Bank N.V.

DNA

7 quarters

Position history for ABN AMRO Bank N.V.ABN AMRO Bank N.V.'s holdings in Ginkgo Bioworks Holdings, Inc.

As of its Q2 2024 13F, ABN AMRO Bank held 200,641 shares of DNA, worth $67,606. ABN AMRO Bank's 13F filings listed DNA from Q1 2023 to Q2 2024, 6 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$668,122

Total Shares Change

-500,596

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$8.09
0
2024-Q2
Decreased
200,641
-12.6%
$67,6060.0%$13.36
0
2024-Q1
Decreased
229,648
-4.8%
$266,2190.0%$46.40
0
2023-Q4
Decreased
241,330
-27.0%
$409,6190.0%$67.60
0
2023-Q3
Decreased
330,625
-27.1%
$599,3360.0%$72.40
0
2023-Q2
Decreased
453,498
-9.4%
$842,5010.0%$72.40
0
2023-Q1
First report
500,596
-
$668,1220.0%$49.20
0

Other major holders of DNA: Viking Global Investors LP, Baillie Gifford & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used